Maternal autoimmune bullous disease
| Maternal autoimmune bullous disease | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Blister formation, pruritus, erythema |
| Complications | Preterm birth, fetal growth restriction |
| Onset | During pregnancy |
| Duration | Varies, often resolves postpartum |
| Types | N/A |
| Causes | Autoimmune response against skin components |
| Risks | Previous history of autoimmune diseases, genetic predisposition |
| Diagnosis | Clinical examination, skin biopsy, immunofluorescence |
| Differential diagnosis | Pemphigoid gestationis, pemphigus vulgaris, bullous pemphigoid |
| Prevention | |
| Treatment | Corticosteroids, immunosuppressants |
| Medication | Prednisone, azathioprine |
| Prognosis | Generally good with treatment, but may affect pregnancy outcomes |
| Frequency | Rare |
| Deaths | N/A |
Maternal autoimmune bullous disease is a rare condition that affects pregnant women and their newborns. It is characterized by the formation of blisters on the skin and mucous membranes. This condition is caused by the transfer of autoantibodies from the mother to the fetus during pregnancy.
Causes[edit]
Maternal autoimmune bullous disease is caused by the transfer of autoantibodies from the mother to the fetus during pregnancy. These autoantibodies target proteins in the skin and mucous membranes, leading to the formation of blisters.
Symptoms[edit]
The main symptom of maternal autoimmune bullous disease is the formation of blisters on the skin and mucous membranes. These blisters can be painful and may rupture, leading to the formation of ulcers.
Diagnosis[edit]
The diagnosis of maternal autoimmune bullous disease is based on the clinical presentation and the results of laboratory tests. These tests may include a skin biopsy, direct immunofluorescence microscopy, and serological tests.
Treatment[edit]
The treatment of maternal autoimmune bullous disease is aimed at reducing the symptoms and preventing complications. This may include the use of topical and systemic corticosteroids, immunosuppressive drugs, and intravenous immunoglobulin.
Prognosis[edit]
The prognosis of maternal autoimmune bullous disease is generally good. Most patients respond well to treatment and the condition usually resolves after delivery.
See also[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
